CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Giraudo Bryan Director | Grant or award · Stock Option (right to buy) | +6,584 | 6,584 | ||
| 2025-01-02 | MOLINA ARTURO MD Chief Medical Officer | Grant or award | +41,088 | 87,532 | ||
| 2025-01-02 | MOLINA ARTURO MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +49,862 | 49,862 | ||
| 2025-01-02 | Ali Asif Chief Financial Officer | Grant or award | +31,779 | 66,739 | ||
| 2025-01-02 | Ali Asif Chief Financial Officer | Grant or award · Stock Option (right to buy) | +38,520 | 38,520 | ||
| 2024-11-27 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +10,000 | $8.04 | $80K | 56,444 |
| 2024-11-27 | MOLINA ARTURO MD Chief Medical Officer | Sale | −10,000 | $44.50 | $445K | 46,444 |
| 2024-11-27 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +16,000 | $8.04 | $129K | 62,444 |
| 2024-11-27 | MOLINA ARTURO MD Chief Medical Officer | Sale | −16,000 | $44.83 | $717K | 46,444 |
| 2024-11-27 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 111,971 | ||
| 2024-11-27 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −16,000 | 95,971 | ||
| 2024-11-26 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +5,529 | $8.04 | $44K | 51,973 |
| 2024-11-26 | MOLINA ARTURO MD Chief Medical Officer | Sale | −5,529 | $45.60 | $252K | 46,444 |
| 2024-11-26 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,529 | 121,971 | ||
| 2024-11-26 | Gupta Suneel Chief Development Officer | Option exercise | +30,000 | $12.17 | $365K | 286,174 |
| 2024-11-26 | Gupta Suneel Chief Development Officer | Sale | −19,191 | $45.50 | $873K | 266,983 |
| 2024-11-26 | Gupta Suneel Chief Development Officer | Option exercise | +450 | $12.17 | $5K | 267,433 |
| 2024-11-26 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) | −30,000 | 93,750 | ||
| 2024-11-26 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) | −450 | 93,300 | ||
| 2024-11-26 | PATEL DINESH V PH D President and CEO | Sale | −21,480 | $46.25 | $993K | 408,455 |
Page 10 of 29 · 580 trades